Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12). (Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021)